Artificial Intelligence technology shows promise in advancing pathology imaging, which can benefit cancer patients through more precise diagnosis leading to targeted treatment.Collaboration with PathAI
SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) has entered an agreement with PathAI, a provider of artificial intelligence-powered technology for pathology. The collaboration, which builds on Roche's
Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that it has entered an agreement with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the development and distribution agreement, the companies will jointly develop an embedded image analysis workflow for .
F Hoffmann-La Roche Ltd: Roche opens access to pathology imaging tools to improve patient care finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.